This Phase II randomized controlled trial is testing the efficacy of a cell phone application called START for helping men who use stimulants like methamphetamine to get the most out of their HIV treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
286
The START mHealth intervention is a mobile application that will be downloaded by participants through their mobile phones. The application targets information, motivation, and behavioral skills relevant to ART adherence. Participants will have access to this application for 6 months.
Florida International University
Miami, Florida, United States
Unsuppressed HIV Viral Load
Proportion of participants with a viral load \> 300 copies/mL from dried blood spot samples
Time frame: 6 Months
Unsuppressed Viral Load
Proportion of participants with a viral load \> 300 copies/mL from dried blood spot samples
Time frame: 12 Months
Self-Reported Stimulant Use Severity
The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) provides validated composite scores indexing the severity of cocaine and amphetamine use (Mild = 0-3; Moderate = 4-26; Severe = 27 or greater).
Time frame: 12 Months
Self-Reported Anti-Retroviral Therapy (ART) Adherence
Participants will rate on a visual analogue scale the percentage (0% meaning no adherence to 100% meaning complete adherence) of ART medications that they took in the past 30 days
Time frame: 12 Months
Positive Affect
Mean positive affect score as measured by the modified Differential Emotions Scale (Range 0-104) with higher scores being indicative of higher positive affect.
Time frame: 12 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.